Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hCG for Acute Graft-versus-host Disease
NCT06904599Phase 2Recruiting
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Feb 2025
- Primary completion
- Jan 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human chorionic gonadotropin in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Started Feb 2025; status: recruiting.
02
Drugs
human chorionic gonadotropin
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT06904599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06904599.